Options
A mechanistic rationale for the investigation of sodium–glucose co‐transporter 2 inhibitors in heart failure with preserved ejection fraction. Letter regarding the article ‘Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR‐Preserved trial’
ISSN
1388-9842
Date Issued
2021
Author(s)
DOI
10.1002/ejhf.2091